4180282/2025-AQ.CENTRAL A23149-ABEMACICLIB 50MG and 150 MG COMP REVES
About This Opportunity
TranslatedThis tender, identified by reference number 4180282/2025-AQ.CENTRAL A23149, concerns the procurement of Abemaciclib, a pharmaceutical compound available in 50mg and 150mg strengths, presented as coated tablets (COMP REVES). Abemaciclib is a targeted therapy drug, specifically a cyclin-dependent kinase (CDK) inhibitor, primarily used in the treatment of certain types of breast cancer, particularly hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. The tender likely seeks to secure a supply of this critical medication for healthcare facilities or public health programs. The reference A23149 suggests a specific product code or internal designation within the procuring entity's system. The "AQ.CENTRAL" likely indicates a central procurement or acquisition process. The tender details will specify the quantities required, delivery timelines, quality standards, and submission requirements for interested pharmaceutical suppliers. Compliance with relevant pharmaceutical regulations and Good Manufacturing Practices (GMP) will be essential for bidders. This procurement is crucial for ensuring patient access to advanced cancer treatments.
This is a supplies contract in the health and medical services, trade and industry and transport and logistics sectors, with a focus on Pharmaceuticals, Logistics and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 31,570.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, originating from Portugal and published on the BASE public contracts portal, seeks the supply of pharmaceutical products. Specifically, the procurement concerns Abemaciclib, available in both 50 mg and 150 mg strengths, presented as a composite reversible formulation. The contracting authority, operating within Portugal's national healthcare system, is looking to establish a supply agreement for these essential medications.
This procurement is typical of a pharmaceutical tender, requiring potential suppliers to demonstrate their capability to provide high-quality, registered medicinal products that meet rigorous regulatory standards. Prospective bidders will likely need to submit detailed product specifications, manufacturing site information, and evidence of compliance with Good Manufacturing Practices (GMP). Furthermore, proposals may need to address aspects such as packaging, labeling in compliance with Portuguese regulations, and secure, timely delivery logistics to designated healthcare facilities. The tender also implies a need for a reliable supply chain to ensure uninterrupted availability of the specified Abemaciclib formulations for patient treatment. Interested parties are encouraged to review the full tender documentation on the BASE portal for specific eligibility criteria, submission deadlines, and detailed technical requirements.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 10, 2026. Last refreshed 3 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Arco Ribeirinho, E.P.E.
Unidade Local de Saúde do Arco Ribeirinho, E.P.E. has issued 554 procurement notices on BidsFactory, including 2 currently open and 548 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to LILLY FARMA, LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Arco Ribeirinho, E.P.E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €31,570. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.